4J5J | Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Amprenavir | date | 2013-02-08 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Shen, C.H., Weber, I.T. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.80 | ||||||||||||
ligand | 478, CL | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Extreme Multidrug Resistant HIV-1 Protease with 20 Mutations Is Resistant to Novel Protease Inhibitors with P1'-Pyrrolidinone or P2-Tris-tetrahydrofuran., Agniswamy J, Shen CH, Wang YF, Ghosh AK, Rao KV, Xu CX, Sayer JM, Louis JM, Weber IT, J Med Chem. 2013 May 1. PMID:23590295 |
Data retrieval |
View 4J5J in 3D |
Visual 3D analysis of 4J5J |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4J5J |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |